Remove Clinical Design Remove Clinical Research Remove Drugs
article thumbnail

Global decentralized studies will become a standard clinical trial design approach

The Pharma Data

After a year of unprecedented disruption in the clinical research industry, 2021 is set to be another transformative year for sponsors and contract research organizations (CROs), according to John Reites, president of Thread, a technology and service provider focusing on decentralized clinical research.

article thumbnail

How Can You Manage the Complexity of Early Phase Clinical Development?

XTalks

In the ever-evolving landscape of pharmaceutical development, the complexity of early phase clinical trials is increasing. This surge in complexity is driven by escalating drug development costs, heightened competition and advanced scientific innovations. The intellectual property involved in these trials has also become more complex.